GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $370,000 | +7.2% | 8,502 | +7.1% | 0.15% | +33.6% |
| Q1 2022 | $345,000 | 0.0% | 7,938 | +1.3% | 0.11% | +15.3% |
| Q4 2021 | $345,000 | +15.0% | 7,838 | -0.1% | 0.10% | +12.6% |
| Q3 2021 | $300,000 | +4.5% | 7,843 | +8.6% | 0.09% | +6.1% |
| Q2 2021 | $287,000 | +12.5% | 7,224 | +1.3% | 0.08% | +2.5% |
| Q1 2021 | $255,000 | – | 7,134 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |